Characterizing PAI-1 Modulation on Monocyte Adhesion

NCT00512031 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2011-07-18

No results posted yet for this study

Summary

To determine how altering the expression of a gene known as PAI-1 may affect the adhesive capacity of cells that play a critical role in the developement of human atherosclerosis.

Conditions

Sponsors & Collaborators

  • Vanderbilt University

    lead OTHER

Principal Investigators

  • Mohan Sathyamoorthy, MD · Vanderbilt University

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2011-07-31
Completion
2011-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00512031 on ClinicalTrials.gov